Navigation Links
Nyer Medical Group, Inc. Reports Revenues of $71.2 Million With Net Loss of $.10 Per Share for Fiscal Year 2008
Date:10/14/2008

BANGOR, Maine, Oct. 14 /PRNewswire-FirstCall/ -- Nyer Medical Group, Inc. (Nasdaq: NYER) reported results for the fiscal year ended June 30, 2008. Revenues for the fiscal year ended June 30, 2008 increased $6.6 million or 10.2% to $71.2 million from $64.6 million as reported for the previous fiscal year. Net loss for the fiscal year ended June 30, 2008 was $403,520 or $.10 per share as compared to a net income of $86,446 or $.02 per share for the previous fiscal year.

The net loss reflects restructuring costs related to the acquisition of the remaining 20% minority interest in D.A.W., Inc. (D.A.W.) and the change in control of the Company, totaling approximately $1.4 million or $.34 per share for the fiscal year ended June 30, 2008. The restructuring costs included a $399,997 charge attributable to the purchase of Class A and B (Series 1) Preferred Stock from the family of Samuel Nyer; legal expense of $586,000 and a severance charge attributable to the non-renewal of the former chief executive officer's employment contract of $118,000. This was partially offset by a net gain of $87,102 or $.02 per share from discontinued operations. Per share results break out as follows: income from continuing operations of $.22 per share, income from discontinued operations of $.02 per share and a loss from restructuring activities of $.34 per share.

The increase in annual revenues was primarily the result of a 4.75% increase in the number of prescriptions dispensed at stores open more than one year, the acquisition of a pharmacy in July 2007, and the addition of three new pharmacies in April and December 2007, and February 2008, respectively. Stores open more than one year experienced a 2.4% growth in revenue.

Net income for the quarter ended June 30, 2008 was $345,184 or $.09 per share as compared to $51,521 or $.02 per share for the same period the previous fiscal year. All but $1,831 of the profit resulted from continuing operations. Revenues for the quarter ended June 30, 2008 increased $1.73 million to $18.5 million from $16.8 million for the same period the previous fiscal year.

The Company had discontinued operations which consisted of its medical segment and fire and police segment. The medical segment located in Florida was sold in June 2008. In September 2008, the medical segment located in Maine sold certain assets and transferred certain liabilities. The purchaser was also granted and option to buy the medical segment's building and land, which were retained by Nyer along with responsibility for the line of credit.

"Fiscal 2008 was an eventful year for Nyer Medical Group," stated President and CEO Mark Dumouchel. "The Company successfully concluded the acquisition of the minority interest in its pharmacy subsidiary, saw the transference of the control position of the Company from the Nyer family to the former minority shareholders of the pharmacy subsidiary and successfully divested the medical segment." Dumouchel further stated, "The Company is poised to move forward focusing exclusively on endeavors aligned with its core competence within Community Pharmacy. We believe there are many opportunities available to the Company that will prove to be profitable for the Company and ultimately valuable to its shareholders."

About Nyer Medical Group

Nyer Medical Group, Inc. is a holding company that through its pharmacy subsidiary operates pharmacies in the greater Boston area.

For further information contact Mark Dumouchel (508) 429-8506, ext. 16.

Safe Harbor for Forward-Looking Statements

Certain statements contained in this press release are forward-looking in nature within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These statements are generally identified by the inclusion of phrases such as "we expect", "we anticipate", "we believe", "we estimate" and other phrases of similar meaning. For example, the statements regarding opportunities in the pharmacy business that will prove to be profitable and valuable to shareholders all involve forward- looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those contemplated in the forward-looking statements. Such factors include, but are not limited to: 1) The continuing opportunities for acquisitions, establishment of FQHC relationships and success in consolidation of administration and elimination of overhead; and 2) Changes in capital equity markets. Additional factors are described under "Part I. Item 1. A. - Risk Factors" in our most recent Annual Report on Form 10-K as filed with the Securities and Exchange Commission. Except as required by law, Nyer Medical Group undertakes no obligation to release publicly the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Nyer Medical Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
2. Spring Point Project Welcomes Second Generation Medical-Grade Piglets
3. VNUS Medical Technologies to Report Third-Quarter 2008 Results and Webcast Teleconference on October 29
4. Radi Medical Systems AB and GE Healthcare Announce Cooperation to Integrate FFR and PressureWire(R) Aeris in GE Mac-Lab(R) IT
5. Arobella Medical CEO is Issued U.S. Patent for Ultrasound Wound Therapy Technology
6. Totoku Europe Chooses Matrox Xenia(TM) Series to Drive Medical Monitors
7. Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity
8. Suzanne Somers, Renowned Author, Medical Advocate, and Official Spokesperson for NeoStem, Inc., Inspires the Audience on The Ellen Degeneres Show
9. Radi Medical Systems Announces Schedule for TCT 2008
10. EnrichMap Announces New Program To Reduce Medical Patient Noncompliance And Offers Healthcare Organizations A Limited Trial Test Opportunity
11. ACIST Medical Systems Announces the Opening of Its New Expanded Corporate Headquarters in Eden Prairie, MN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Wells, CA (PRWEB) , ... January 21, 2017 ... ... in our ongoing endeavors to bring to market a pioneering medical device for ... O’Rourke, has signed an engagement contract with Emergo, a global regulatory consultancy that ...
(Date:1/21/2017)... 21, 2017   Boston Biomedical , an industry ... target cancer stemness pathways, today presented data from two ... the 2017 American Society of Clinical Oncology (ASCO) Gastrointestinal ... In a Phase Ib/II study of ... inhibit cancer stemness pathways by targeting STAT3 – colorectal ...
(Date:1/20/2017)... , January 20, 2017 ... cancer is one of leading causes of death worldwide. ... Although the number of cancer related deaths increased gradually ... Rising in incidence rate of various cancers continues to ... a research report by Global Market Insights, Inc. cancer ...
(Date:1/19/2017)... and HOUSTON , Jan. 19, ... today announced the formation of its Medical/Clinical Advisory ... and industry veterans who enhance the range and ... accelerates development of its novel prenatal diagnostic tests.  ... clinical and strategic guidance for the company,s product ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... sensor technology, today announced the launch of two ... systems, the highly-accurate biometric sensor modules that incorporate ... technology, experience and expertise. The two new designs ... specifically for hearables, and Benchmark BW2.0, a 2-LED ...
(Date:12/20/2016)... Dec. 20, 2016 The rising popularity ... and leasing is stoking significant interest in keyless ... technology, Bluetooth low energy (BLE), biometrics and near-field ... next wave of wireless technologies in the automotive ... to advanced access systems opens the market to ...
Breaking Biology News(10 mins):